This work is motivated by the drug therapy scheduling problem in HIV infection. Using simplified switched linear system models of HIV mutation and treatment with certain class of symmetry and finite horizon cost functions, we demonstrate that the optimal state and costate trajectories lie on a sliding surface where infinitely fast switching may occur. Results suggest that in the absence of other practical constraints, switching rapidly between therapies is relevant. Simulations show the potential benefits of a proactive switching strategy to minimize viral load and delay the emergence of resistant mutant viruses.
Introduction
Highly active antiretroviral therapies (HAARTs) provide a rapid drop in plasma viral load with a large reduction of infected cells in patients with HIV infection. Even though long periods of HAART are provided, latently infected cells are still detectable. Therefore, cellular reservoirs may contribute to HIV persistence promoting the emergence of resistant mutants (Eisele & Siliciano, 2012) .
In the recent treatment guidelines for HIV infection (AIDSinfo, 2011), clinicians did not achieve a consensus on the optimal time to change therapy in the event of virological failure (inability to maintain HIV RNA levels less than 50 copies/ml under HAART treatment). A widely accepted strategy (which we refer to as ''switch on virological failure'') is to continue the current therapy until the viral load exceeds a fixed level (e.g. 1000-500 copies/ml). Using a mathematical approach D'Amato, DAquila, and Wein (1998) proposed that alternating between therapies may delay the emergence of resistant mutant viruses. A preliminary clinical evaluation ✩ Supported by Science Foundation Ireland 07/IN/I1838. This work was performed in part whilst the authors were at the Hamilton Institute, The National University of Ireland, Maynooth. The material in this paper was partially presented at the IFAC Symposium Nonlinear Control Systems (NOLCOS 2010) , September 1-3, 2010, Bologna, Italy. This paper was recommended for publication in revised form by Associate Editor David Angeli under the direction of Editor Andrew R. Teel.
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of proactive switching was performed in Martinez-Cajas and Wainberg (2008) . In this initial trial alternating regimens appeared to outperform virological failure based treatment. Therefore switching between treatments may be crucial to minimize the risk of resistance (Craig & Xia, 2005; Luo, Piovoso, Martinez-Picado, & Zurakowski, 2011; Ouattara, Mhawej, & Moog, 2008) . Under several simplifying assumptions, Hernandez-Vargas, Colaneri, Middleton, and Blanchini (2010) expressed the drug treatment scheduling problem of HIV infection as an optimal control application for a specific class of autonomous positive switched systems of the following form:
Σ A :ẋ(t) = A σ (x(t)) x(t),
where σ : R n + → I = {1, . . . , N} denotes the treatment selection and A σ is a family of n × n matrices. The system (1) is positive if the non-negative orthant is positively invariant for any switching signal. Positivity is well known to be equivalent to all matrices A σ being Metzler, that is, a ij ≥ 0 for any i ̸ = j (Farina & Rinaldi, 2000) .
Optimal control of hybrid systems has been widely studied (Cassandras, Pepyne, & Wardi, 2001; Dmitruk & Kaganovich, 2008 , 2011 Spinelli, Bolzern, & Colaneri, 2006) . The problem studied in this paper is closely related to the variational approach to the stability of switched systems previous developed by Boscain (2002) , Margaliot (2006) and Rapoport (1996) . We provide an analytic solution for a particular class of switched systems using sufficient conditions via the necessary conditions based on the Pontryagin principle. For simplicity no constraints or penalty terms are imposed on the switching. The cost functional is in the following form: where c is a strictly positive vector. Note that this final time penalty is motivated by the observation that frequently the final viral escape is at an exponential rate that is largely independent of the treatment selection. Thus, the terminal cost (2) is a surrogate for delaying the escape time. The paper is organized as follows: optimal control for switched systems is reviewed in Section 2. We apply these results to mutating HIV infection models under drug therapy in Section 3. Simulations are given in Section 4 followed by conclusions and future work in Section 5.
Optimal control problem
Consider the switched system (1) of dimension n, with σ (t) ∈ {1, 2, . . . , N} and the cost (2). When dealing with switched systems we can encounter sliding trajectories, i.e. infinite frequency switching of σ (t). To include sliding trajectories, we embed the switched system in the larger class described bẏ
Remark 1. Clearly by construction the system (3) includes the system (1). It may be that for some t, u(t) is not a vertex of the simplex, and there is no directly equivalent σ (t). However (for example Bai & Yang, 2007) , note that the set of possible trajectories of (1) are dense in the set of trajectories generated by (3). Therefore, extending the concept of valid switching signals to sliding modes based on the appropriate differential inclusions, we consider optimal control of the system (3). For further details of the related viscous solutions of differential equations and optimal control of differential inclusions see Bardi and Capuzzo-Dolcetta (2008) and Brandi and Salvadori (1998) , respectively. The role of sliding modes (singular control) in optimization problems in terms of finite time convergence to the sliding surface is emphasized in McDonald (2008) .
(for almost all t) the system of equations:
with the boundary conditions x 
Proof. Write the Hamiltonian function
and notice thatπ (
Moreover, the transversal conditions are satisfied and for all u ∈ U: 
with the boundary condition
This is however not enough to guarantee that any Pontryagin solution is also optimal, even though no counterexample for switched linear positive systems with positive linear cost has been worked out in the literature. Besides uniqueness, another sufficient condition ensuring optimality of a Pontryagin solution is the convexity of the functional c ′ x(t f ) with respect to u ∈ U. These topics will be the subject of future work.
Note that if u o (t) lies at a vertex of U, then an admissible switching signals (i.e. signals σ (t) ∈ {1, 2, . . . , N} for almost all t), σ o (t) can be constructed, see Spinelli et al. (2006) , as follows:
with the boundary conditions x
Optimal therapy scheduling: special cases
Simulations and clinical data suggest that once the patient is using HAART and until virological failure, macrophage and CD4 +T cell counts are approximately constant (Perelson & Nelson, 1999) . Under this assumption, most nonlinear HIV models (HernandezVargas & Middleton, 2013) 
where
is the replication rate for viral genotype (i) and therapy combination σ , µ represents the mutation rate, δ V is the viral clearance and m i,j ∈ {0, 1} represents the genetic connections between genotypes, that is, m i,j = 1 if and only if it is possible for genotype j to mutate into genotype i. Motivated by the HIV treatment application, we provide solutions based on the Pontryagin principle for particular subclasses of the model (7). These subclasses are restrict to N = 2, that means there are only two available treatments. In this case, the optimal control (6) may be a sliding mode when the decision variable γ (t)
vanishes on a non-trivial interval, where:
Invariant subspaces
One problem of interest is when x and π evolve on a particular invariant subspace as in the lemma below.
Lemma 1.
Consider the dynamic system (1) with initial condition
Then there exists a Pontryagin solution over t ∈ [0, t f ] that is a sliding mode.
Proof. Our claim is that: 
Generalized symmetry
An important case where the invariant subspace assumptions of Lemma 1 applies is when a particular kind of symmetry holds. In fact, the result applies also to a certain generalization of this symmetry as we shall see below. To this end, we first introduce a (generalized) transposition assumption.
Definition 2. A matrix T ∈ R
n×n is called a (generalized) transposition if there exists a matrix v ∈ R n×m such that:
Note, for example, that with k = 2 in Definition 2, T is precisely a transposition with T 2 = I. Assumption 1. The matrix A 2 may be obtained as a (generalized) transposition of A 1 , namely, there exists a transposition T such that:
The following lemma shows how this assumption may be used to construct an invariant subspace.
Lemma 2. Under Assumption 1, v
′ is a basis for a left invariant
Proof. Using (11) we may rewrite A α as
Substituting (9) in A α we obtain
′ by the left, and using (10), we have
We now extend this result to show how it may be used to find optimal switching controls.
Theorem 2. Under the following conditions:
i. Assumption 1;
ii. 
Proof. The proof follows directly from Lemmas 1 and 2 and the fact that the left and right invariant subspaces are equivalent for the symmetric matrix A α . Condition (v) of Lemma 1 can be established as follows:
Note that as well as the matrix version of symmetry, A
there is also a permutation symmetry here. In particular, T is now idempotent, and the dynamics under the two treatment options are identical apart from relabelling of some of the state variables. Furthermore, the conditions that the initial conditions and costate start on the invariant subspace are equivalent to equal weighting and initial conditions on state variables that are transposed under T . We therefore see that certain kinds of symmetric problems generically admit Pontryagin solutions that are a sliding mode.
Next we look at a specific class of systems for which this solution is optimal.
General solution for a 4 variant model
Consider a system with 4 states, and two treatment options, N = 2 of the following structure, see Middleton et al. (2010) . In addition, we make the following symmetry assumption: 
Moreover, from the structure of A 1 and A 2 it is possible to conclude thaṫ
The following lemma, which can be proven directly from (12) and Assumption 2 is useful to characterize the optimal solution. In the following the sign function
Lemma 3. Under Assumption 2 the following conditions hold for any Pontryagin solution, x(t), π (t), u(t):
To characterize the sliding modes, it is necessary to find a suitable convex combination of the matrices A 1 , A 2 as follows: ′ . The remainder of the proof follows that of Lemma 1.
For the future proof of optimality, we establish positive invariance of certain regions for any Pontryagin solutions to the optimal control problem.
Lemma 5. With respect to any Pontryagin solution, and subject to Assumptions 2 and 3, the following regions are positively invariant:
Proof. We prove this result for R +1 only as the other case follows similarly. Note thatγ > 0 implies that u 1 = 0 and thereforė
Furthermore, from (13), in this regionγ ≥ 0. Now define k 1 = argmin{x 2 (0), x 3 (0)}, k 2 = argmin{c 2 , c 3 }, and
Notice that, thanks to the definition of k 1 , k 2 and the monotonicity conditions of x 2 (t)−x 3 (t), π 2 (t)−π 3 (t), the time instants T 1 and T 2 are well defined and unique. Clearly, by definition x 2 (T 1 ) = x 3 (T 1 ) and π (T 2 ) = π 3 (T 2 ). We are now in the position to provide the main result for the four variant model (recall that σ = 1 means u 1 = 1, σ = 2 means u 1 = 0 and a sliding mode corresponds to the singular arc associated with u 1 = α).
Theorem 3 (Long Horizon Case). Let Assumptions 2 and 3 be met, let
µ > 0 and assume that T 1 ≤ T 2 . Then, the optimal control associated with the initial state x(0) and cost c
, the optimal control is given by the trajectory along the plane x 2 = x 3 , with dynamical matrix A α = αA 1 + (1 − α)A 2 and α as given in Lemma 2.
Proof. We first define our candidate optimal solution triple as follows:
we have x 2 (t) = x 3 (t) and π 2 (t) = π 3 (t), and therefore the Pontryagin conditions are satisfied in this interval.
For the remaining two intervals t ∈ [0, T 1 ] (i = 1) and t ∈ [T 2 , t f ] (i = 2), considerγ (12), andγ (13). Now,γ (T 1 ) =γ (T 2 ) = 0 and, for t ∈ [0, T 1 ] or t ∈ [T 2 , t f ]:
This means that, for t ∈ [0,
Therefore, within either time interval, the sign ofγ is uniform:
Sinceγ (T i ) = 0 for i = 1, 2 it follows that the sign ofγ is uniform within either time interval, and takes the required sign to satisfy the Pontryagin conditions.
We now have to show that the proposed Pontryagin solution,
u(t), x(t), π (t)
is unique so that optimality follows. We do this by considering other candidate Pontryagin solutions and producing a contradiction, thereby establishing that the proposed solution is optimal.
To this end, consider Figs. 1 and 2 , that correspond to the case that shows the four orthants in the coordinates x 2 −x 3 and π 2 −π 3 , labeled inγ andγ . Notice also that in the case µ ̸ = 0 the only point for whichγ = 0 andγ = 0 is the origin, i.e. x 2 = x 3 and π 2 = π 3 . Case (a): π 2 (0) − π 3 (0) ≤ 0. Since we have also assumed x 2 (0) < x 3 (0) it follows thatγ (0) < 0 and u 1 (0) = 1. Then initially, x 2 (t) − x 3 (t) increases and π 2 (t) − π 3 (t) decreases. Therefore, there is an initial time interval [0, τ 1 ] whereinγ (t) < 0,π 2 < π 3 , and therefore π 2 (t) < π 3 (t). These conditions persist unless we reach x 2 = x 3 . However, at this point we have entered the positively invariant region R +2 . Therefore, in this case, we must haveγ < 0 and π 2 < π 3 over the entire time interval. However, this contradicts either:
(ii) if c 2 < c 3 the long horizon assumption on the existence of T 2 which yields π 2 (T 2 ) = π 3 (T 2 ).
In this case, we start in R +1
and therefore remain in this region. In a similar manner to case (a), this produces a contradiction with respect to either the final value of the costate, or the existence of T 2 .
Case (c):
then at some small time later we are effectively in case (b) and the contradiction there holds. Thereforeγ (t) remains negative until some t = τ 1 > 0. Suppose τ 1 < T 1 , then by the definition of T 1 , x 2 (τ 1 ) < x 3 (τ 1 ), and therefore to satisfyγ (τ 1 ) = 0 we must have π 2 (τ 1 ) > π 3 (τ 1 ). Then just after t = τ 1 we enter R +1 and remain there, and as in cases (a), (b) this leads to a contradiction. Suppose instead that τ 1 > T 1 . Then for t ∈ (T 1 , min{τ 1 , T 2 }), it must be true that x 2 (t) > x 3 (t) andγ (t) < 0. This implies that π 2 (t) < π 3 (t)
and therefore we are in R +2 and a similar contradiction to before holds. Therefore, the only case that does not lead to a contradiction is thatγ (t) reaches zero precisely at t = T 1 , x 2 (T 1 ) = x 3 (T 1 ) and π 2 (T 1 ) = π 3 (T 1 ) as in the proposed solution.
By reversing the same logic, we can show that the final time interval must be of the form postulated, Even though in practice the horizon length t f may often be large enough to guarantee that T 1 ≤ T 2 , for completeness, we shall consider the small horizon case.
Theorem 4 (Small Horizon Case). Let Assumption (2) be met, assume
µ ̸ = 0 and 0 < T 2 ≤ T 1 < t f . Then, the optimal control associated with the initial state x(0) and cost c ′ x(t f ) is given as follows:
Proof (Outline). The proof follows similar steps of Theorem 3 and we therefore abbreviate many of the details. We first verify that the proposed control law satisfies the Pontryagin conditions (3).
Consider case (i) k 1 = k 2 (see Fig. 3 ). Also take k 1 = 1, with the other case following by symmetry. Our candidate solutions are
and for all t, u 1 (t) = 1. It remains to confirm that this satisfies the decision condition, (6). Note that by definition of T 2 , x 2 (t) − x 3 (t) changes sign only at t = T 2 . Similarly, π 2 (t) − π 3 (t) changes sign only at t = T 1 . For t ∈ [max{0, T 2 }, min{T 1 , t f }] both x 2 (t) − x 3 (t) and π 2 (t) − π 3 (t) are both negative, and thereforeγ (t) < 0 as required. A further two regions may need to be considered, [0,
In these regions we haveγ (t) > 0,γ (t) < 0 respectively, and thereforeγ (t) < 0 for the entire interval t ∈ [0, t f ]. Now consider case (ii), k 1 ̸ = k 2 (see Fig. 4 ). We discuss k 1 = 1, k 2 = 2 with the other case following similarly. We first show that T 3 exists. Note that g(T 2 ) is negative and g(T 1 ) is positive.
Uniqueness follows since
where the inequality follows since for our case, (A 1J −JA 2 ) is diagonal and non-negative. Our candidate optimal solution is therefore
From the definition of T 3 , the candidateγ (t) swaps sign at t = T 3 .
We now have to show that the proposed Pontryagin triple is unique. Note that by the definitions of T 1 and T 2 , for any Pontryagin
Now consider three cases. Case (a): π 2 (0) ≤ π 3 (0). This then leads toγ < 0 and therefore π 2 − π 3 decreases. It can be shown that this situation persists and therefore there is a contradiction with the terminal condition, π (t f ) = c. Case (b): π 2 (0) > π 3 (0) andγ (0) > 0. This is part of the set R +1 which is positively invariant, and yields a valid solution only when t f < T 3 < T 1 . Case (c): π 2 (0) > π 3 (0) andγ (0) < 0. This yieldsγ (0) > 0 and the solution is as postulated wherein
Reversing the argument to work backwards from t = t f , gives the solution postulated, including possible cases where T 3 exists, but is outside the range (0, t f ).
Remark 4. Theorem 4 implicitly includes cases where one or more of T 1 , T 2 and T 3 are outside the range (0, t f ).
Remark 5. Suppose µ = 0. Then, the matrices of the system commute, and existing results (e.g. see Agrachev and Liberzon (2001) and Margaliot (2007) ) can be applied. In our case (diagonal matrices), it is possible to prove that an optimal control is described by a single switch of duration
where x(t f ) σ =1 denotes the state vector at time t f evaluated with σ = 1. This solution is non-unique, and for symmetric initial conditions, and under Assumptions 2 and 3, the sliding mode control, u 1 (t) = α is also optimal.
Simulation results
HIV treatments are designed to require the accumulation of three or more resistance mutations before the appearance of a fully resistant variant. This would give a complex scenario with a much higher degree of complexity. To illustrate the results of Section 3, we propose a 4 variant, 2 drug treatment model, with an initial condition vector x = [10 3 , 5, 0, 10
] and a symmetric cost function weighting as c = [1, 1, 1, 1] ′ . The viral clearance rate is δ V = 0.24 day −1 , which corresponds to a half life of less than 3 days (Perelson & Nelson, 1999) . Notice that other authors (Huang, Wu, & Acosta, 2010; Luo, Piovoso, Martinez-Picado, & Zurakowski, 2012; Putter, Heisterkamp, Lange, & De Wolf, 2002) suggest a slightly faster clearance rate, approximately 1 per day. Viral mutation rates are of the order of µ = 10 −4 (Mansky, 1996) . The various replication rates are described in the Table 1 , these numbers are of course idealized, however the general principles are based on Hernandez-Vargas et al. (2010) . For an optimal treatment, using Theorem 3, therapy 2 is used for t < T 1 = 12.2 days, then therapies alternate with high frequency as illustrated in . The wild type virus is attenuated to undetectable levels (less than 50 copies/ml). The highly resistant genotype grows slowly which induces the final viral escape. Fig. 6 (b) reveals how the costate dynamics are similar to the state, but in reverse time.
Remark 6. Optimal trajectories are associated with chattering switching laws that are of course not realistically applicable for HIV treatment. However, this theoretical result provides an important insight since it clarifies when the therapies have to be switched more frequently in order to better control viral load. In order to accommodate the need for a lower bound on the commutation intervals, future works will address the problem of incorporating a dwell time constraint for the switching signal.
Using a switch on virological failure strategy, the therapy is changed after 9 months (when viral load ≥1000 copies/ml).
Therefore, the population of the resistant genotype is large enough that it that cannot be contained by the second therapy, see Fig. 7 . In contrast, proactive switching may reduce viral load to very low levels during the whole treatment, 100 copies/ml, promoting a larger delay in the viral escape.
Notice that an open loop alternating strategy and the optimal control present close performance for this example. This means that a periodic oscillating strategy might be effective in postponing viral escape without requiring a detailed model, high computational time and full state measurements.
Conclusions
For the proposed models of treatment in HIV and simplifying assumptions in the proliferation rate and the mutation graph, we show that the optimal control for a class of positive switched systems is given by the trajectory along the plane v ′ x(t) = 0 with dynamical matrix A α . Such behavior suggests that in the absence of other practical constraints, switching rapidly between therapies may be desirable. This work provides the speculative possibility that therapy alternation may sustain viral suppression to very low levels inhibiting the emergence of resistant mutant viruses. Further research will include more realistic models and cost functions that penalize the switching.
